ES2111547T3 - Comprimido de liberacion prolongada. - Google Patents

Comprimido de liberacion prolongada.

Info

Publication number
ES2111547T3
ES2111547T3 ES91112313T ES91112313T ES2111547T3 ES 2111547 T3 ES2111547 T3 ES 2111547T3 ES 91112313 T ES91112313 T ES 91112313T ES 91112313 T ES91112313 T ES 91112313T ES 2111547 T3 ES2111547 T3 ES 2111547T3
Authority
ES
Spain
Prior art keywords
component
pharmaceutically active
release tablet
powder
prolonged release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91112313T
Other languages
English (en)
Inventor
Minoru Okada
Tetsuo Hayashi
Shuichi Kasai
Akira Iwasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of ES2111547T3 publication Critical patent/ES2111547T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBE UNA TABLETA DE LIBERACION SOSTENIDA. LA TABLETA ES UNA COMBINACION DE POLVO (A) QUE COMPRENDE UN COMPONENTE DE ACEITE, UN POLIMERO INSOLUBLE EN AGUA, O AMBOS, Y UN COMPONENTE FARMACEUTICAMENTE ACTIVO Y UN POLVO (B) QUE COMPRENDE UN POLIMERO SOLUBLE EN AGUA Y UN COMPONENTE FARMACEUTICAMENTE ACTIVO. SE PUEDE ASEGURAR FACILMENTE UN NIVEL DE LIBERACION IDEAL PARA EL COMPONENTE INDIVIDUAL FARMACEUTICAMENTE ACTIVO AL CONTROLAR SU NIVEL DE LIBERACION AL CAMBIAR LA PROPORCION DE POLVOS (A) Y (B).
ES91112313T 1990-07-25 1991-07-23 Comprimido de liberacion prolongada. Expired - Lifetime ES2111547T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2197019A JP2572673B2 (ja) 1990-07-25 1990-07-25 徐放性錠剤

Publications (1)

Publication Number Publication Date
ES2111547T3 true ES2111547T3 (es) 1998-03-16

Family

ID=16367420

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91112313T Expired - Lifetime ES2111547T3 (es) 1990-07-25 1991-07-23 Comprimido de liberacion prolongada.

Country Status (8)

Country Link
US (1) US5164193A (es)
EP (1) EP0468436B1 (es)
JP (1) JP2572673B2 (es)
KR (1) KR0169319B1 (es)
CA (1) CA2046845C (es)
DE (1) DE69128569T2 (es)
ES (1) ES2111547T3 (es)
TW (1) TW222592B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216934A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
CA2216215A1 (en) 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
FR2771291B1 (fr) * 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
CN100370967C (zh) * 1999-06-04 2008-02-27 阿尔萨公司 埋植凝胶组合物及其制备方法
BR0013719A (pt) 1999-09-02 2002-07-23 Nostrum Pharmaceuticals Inc Dosagem oral de liberaçâo controlada, apropriada para administração oral
US20050037073A1 (en) * 2000-01-13 2005-02-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
WO2002067905A1 (en) * 2001-02-27 2002-09-06 Kos Pharmaceuticals, Inc. A sustained release pharmaceutical formulation
KR100464592B1 (ko) * 2001-04-13 2004-12-31 주식회사 한국팜비오 포타슘시트레이트를 함유한 왁스 매트릭스 타입의 정제와그의 조성물
CA2452871C (en) 2001-07-06 2011-10-04 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
US20050031686A1 (en) * 2002-03-25 2005-02-10 Truffini & Regge' Farmaceutici Srl Gastroresistant tablets for alimentary, dietetic and therapeutic use
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
US20050220877A1 (en) * 2004-03-31 2005-10-06 Patel Ashish A Bilayer tablet comprising an antihistamine and a decongestant
AU2005320547B2 (en) 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20090060993A1 (en) * 2007-09-04 2009-03-05 Joseph Schwarz Solid pharmaceutical composition for enhanced delivery of coenzyme q-10 and ubiquinones
JP5122380B2 (ja) * 2008-06-16 2013-01-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 薬物の放出を制御した速崩錠及びその製法
US8962020B2 (en) * 2012-07-26 2015-02-24 Glycadia Inc. Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid
CA3050082A1 (en) 2016-04-04 2017-10-12 Omeza LLC Fish oil topical composition
KR20200110317A (ko) 2017-12-05 2020-09-23 선오비온 파마슈티컬스 인코포레이티드 결정형 및 이의 제조 방법
KR20200110648A (ko) 2017-12-05 2020-09-24 선오비온 파마슈티컬스 인코포레이티드 비라세믹 혼합물 및 이의 용도
AU2020286441A1 (en) 2019-06-04 2022-01-06 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56122311A (en) * 1980-02-29 1981-09-25 Eisai Co Ltd Lasting theophylline pharmaceutical composition
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione

Also Published As

Publication number Publication date
KR930001899A (ko) 1993-02-22
CA2046845C (en) 2001-03-27
JP2572673B2 (ja) 1997-01-16
KR0169319B1 (ko) 1999-01-15
JPH0482825A (ja) 1992-03-16
DE69128569T2 (de) 1998-04-16
CA2046845A1 (en) 1992-01-26
US5164193A (en) 1992-11-17
EP0468436A1 (en) 1992-01-29
DE69128569D1 (de) 1998-02-12
TW222592B (es) 1994-04-21
EP0468436B1 (en) 1998-01-07

Similar Documents

Publication Publication Date Title
ES2111547T3 (es) Comprimido de liberacion prolongada.
DE69721481D1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
ECSP034455A (es) Forma de dosificacion de farmaco activada por hidrogel
BR0107869A (pt) Composições farmacêuticas eletrogiradas
DK0841904T3 (da) Orale farmaceutiske præparater med forsinket frigivelse af reversible protonpumpeinhibitorer
DK1244401T3 (da) Medikamentdosering af faseændrende formulering
DK0850046T3 (da) Mikroemulsioner til anvendelse som vhikel til indgift af active forbindelser
ATE251449T1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
ES2052016T3 (es) Composicion emulsionada.
DE69123795D1 (de) Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau
CA2177772A1 (en) Pharmaceutical compositions containing irbesartan
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
ES2130638T3 (es) Sistema para la liberacion de sustancia activa, filmogeno, vaporizable, para utilizar en las plantas.
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
EA200200207A1 (ru) Применение антагонистов cgrp и ингибиторов высвобождения cgrp для устранения приливов в период менопаузы
EA200001201A3 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем
ATE311858T1 (de) Dosierungsform mit flüssiger formulierung
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
ES2130081B1 (es) Comprimido de maleato de trimebutina con recubrimiento laminar.
BR9809571A (pt) Composição medicinal e processo para produzì-la
GR3025362T3 (en) Sol-controlled gelatine-based thermocolloidal matrix for peroral prolonged action administration forms.
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
BR0314804A (pt) Forma de dosagem de liberação modificada
ES2191638T3 (es) Comprimidos escasamente dosificados y procedimiento para su preparacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 468436

Country of ref document: ES